title: Cryptococcus neoformans host adaptation: toward biological evidence of dormancy.
abstract: Cryptococcosis is an opportunistic infection due to the ubiquitous yeast Cryptococcus neoformans. This yeast interacts closely with innate immune cells, leading to various fates, including fungal persistence within cells, making possible the dissemination of the yeast cells with monocytes via a Trojan horse strategy. In humans, the natural history of the infection begins with primoinfection during childhood, which is followed by dormancy and, in some individuals, reactivation upon immunosuppression. To address the question of dormancy, we studied C. neoformans infection at the macrophage level (in vitro H99-macrophage interaction) and at the organ level in a murine model of cryptococcosis. We analyzed the diversity of yeast adaptation to the host by characterizing several C. neoformans populations with new assays based on flow cytometry (quantitative flow cytometry, multispectral imaging flow cytometry, sorting), microscopy (dynamic imaging), and gene expression analysis. On the basis of parameters of multiplication and stress response, various populations of yeast cells were observed over time in vivo and in vitro. Cell sorting allowed the identification of a subpopulation that was less prone to grow under standard conditions than the other populations, with growth enhanced by the addition of serum. Gene expression analysis revealed that this population had specific metabolic characteristics that could reflect dormancy. Our data suggest that dormant yeast cells could exist in vitro and in vivo. C. neoformans exhibits a huge plasticity and adaptation to hosts that deserves further study. In vitro generation of dormant cells is now the main challenge to overcome the limited number of yeast cells recovered in our models.
  
  
  OBJECTIVE
  Cryptococcus neoformans is a sugar-coated unicellular fungus that interacts closely with various cells and organisms, including amoebas, nematodes, and immune cells of mammals. This yeast is able to proliferate and survive in the intracellular environment. C. neoformans causes cryptococcosis, and yeast dormancy in humans has been suggested on the basis of epidemiological evidence obtained years ago. By studying an in vitro model of yeast-macrophage interaction and murine models of cryptococcosis, we observed that yeast cells evolve in heterogeneous populations during infection on the basis of global metabolic activity. We compared the growth ability and gene expression of yeast cells belonging to various populations in those two models. We eventually found a population of yeast cells with low metabolism that fit some of the criteria for dormant cells. This paves the way for further characterization of dormancy in C. neoformans.
authors.affiliation: alexandre.alanio@pasteur.fr.
authors.forename: Alexandre
authors.identifier: http://orcid.org/0000-0001-9726-3082
authors.initials: A
authors.lastname: Alanio
authors.forename: Frédérique
authors.initials: F
authors.lastname: Vernel-Pauillac
authors.forename: Aude
authors.initials: A
authors.lastname: Sturny-Leclère
authors.forename: Françoise
authors.initials: F
authors.lastname: Dromer
mesh_terms: D000818:Animals; D003453:Cryptococcosis / Q000382:microbiology* / Q000473:pathology*; D003455:Cryptococcus neoformans / Q000254:growth & development* / Q000378:metabolism; D004195:Disease Models, Animal; D005434:Flow Cytometry; D020869:Gene Expression Profiling; D054884:Host-Pathogen Interactions; D008264:Macrophages / Q000382:microbiology*; D008297:Male; D051379:Mice; D050296:Microbial Viability; D008853:Microscopy
references.citation: Cytometry A. 2003 Jan;51(1):16-25
references.pmid: 12500301
references.citation: J Clin Invest. 2001 Dec;108(11):1639-48
references.pmid: 11733559
references.citation: PLoS Pathog. 2012 Feb;8(2):e1002495
references.pmid: 22383873
references.citation: Infect Immun. 2004 Jun;72(6):3359-65
references.pmid: 15155641
references.citation: Curr Infect Dis Rep. 2007 Nov;9(6):457-64
references.pmid: 17999881
references.citation: Infect Immun. 1994 Jan;62(1):194-202
references.pmid: 8262627
references.citation: Infect Immun. 1987 Mar;55(3):742-8
references.pmid: 3546139
references.citation: Annu Rev Microbiol. 2010;64:293-311
references.pmid: 20825351
references.citation: Fungal Genet Biol. 2010 Dec;47(12):1070-80
references.pmid: 21067947
references.citation: Parasitol Res. 2011 Jan;108(1):247-52
references.pmid: 20924610
references.citation: Cell Cycle. 2009 Aug;8(15):2326-31
references.pmid: 19571671
references.citation: PLoS Med. 2007 Feb;4(2):e21
references.pmid: 17284154
references.citation: Curr Opin Microbiol. 2010 Aug;13(4):437-42
references.pmid: 20570552
references.citation: Infect Immun. 2004 Apr;72(4):2229-39
references.pmid: 15039347
references.citation: MBio. 2011;2(4). pii: e00158-11. doi: 10.1128/mBio.00158-11
references.pmid: 21828220
references.citation: Infect Immun. 2000 Jun;68(6):3642-50
references.pmid: 10816523
references.citation: Am J Pathol. 2005 Feb;166(2):421-32
references.pmid: 15681826
references.citation: J Infect Dis. 2002 Aug 15;186(4):522-30
references.pmid: 12195380
references.citation: Cell Cycle. 2012 May 1;11(9):1680-96
references.pmid: 22510571
references.citation: J Infect Dis. 2011 Jun 1;203(11):1686-91
references.pmid: 21592999
references.citation: MBio. 2010 May 18;1(1):null
references.pmid: 20689743
references.citation: Nat Rev Microbiol. 2010 Dec;8(12):890-6
references.pmid: 20972452
references.citation: Biosci Biotechnol Biochem. 2012;76(6):1085-90
references.pmid: 22790927
references.citation: Microbiology. 2006 Aug;152(Pt 8):2247-55
references.pmid: 16849791
references.citation: G3 (Bethesda). 2013 Apr 9;3(4):675-686
references.pmid: 23550133
references.citation: PLoS Pathog. 2010;6(6):e1000953
references.pmid: 20585559
references.citation: Biochem Mol Biol Int. 1998 Apr;44(4):747-59
references.pmid: 9584988
references.citation: Nat Rev Microbiol. 2011 Mar;9(3):193-203
references.pmid: 21326274
references.citation: Eukaryot Cell. 2013 May;12(5):761-74
references.pmid: 23524994
references.citation: PLoS One. 2012;7(8):e42439
references.pmid: 22879986
references.citation: MBio. 2011;2(4). pii: e00167-11. doi: 10.1128/mBio.00167-11
references.pmid: 21828219
references.citation: J Med Vet Mycol. 1992;30(5):395-7
references.pmid: 1469541
references.citation: PLoS Pathog. 2008;4(9):e1000155
references.pmid: 18802457
references.citation: Annu Rev Microbiol. 2006;60:69-105
references.pmid: 16704346
references.citation: Am J Pathol. 1980 Oct;101(1):177-94
references.pmid: 7004196
references.citation: Infect Immun. 2012 Nov;80(11):3776-85
references.pmid: 22890995
references.citation: Nucleic Acids Res. 2005;33(20):6469-85
references.pmid: 16287898
references.citation: Microbiology. 2003 Apr;149(Pt 4):1041-9
references.pmid: 12686646
references.citation: FEMS Immunol Med Microbiol. 2012 Mar;64(2):147-61
references.pmid: 22029633
references.citation: Nat Commun. 2014;5:5194
references.pmid: 25323068
references.citation: Infect Immun. 2000 Jul;68(7):4225-37
references.pmid: 10858240
references.citation: Biochem Mol Biol Int. 1996 Apr;38(5):901-10
references.pmid: 9132159
references.citation: Microbiol Mol Biol Rev. 2004 Jun;68(2):187-206
references.pmid: 15187181
references.citation: PLoS One. 2009;4(7):e6413
references.pmid: 19641610
references.citation: Biotechniques. 2003 Feb;34(2):374-8
references.pmid: 12613259
references.citation: Proc Natl Acad Sci U S A. 2001 Dec 18;98(26):15245-50
references.pmid: 11742090
references.citation: Nucleic Acids Res. 2001 May 1;29(9):e45
references.pmid: 11328886
references.citation: Infect Immun. 1988 Feb;56(2):424-31
references.pmid: 3123390
references.citation: Clin Microbiol Infect. 2010 Jun;16(6):696-703
references.pmid: 19694765
references.citation: MBio. 2011;2(3):e00100-11
references.pmid: 21673191
references.citation: Int J Food Microbiol. 2004 Nov 15;96(3):289-300
references.pmid: 15454319
references.citation: Infect Immun. 2009 Jan;77(1):120-7
references.pmid: 18936186
references.citation: Proc Natl Acad Sci U S A. 2009 Aug 4;106(31):12980-5
references.pmid: 19651610
references.citation: Res Microbiol. 2008 Nov-Dec;159(9-10):628-34
references.pmid: 18793720
references.citation: J Clin Microbiol. 1999 Oct;37(10):3204-9
references.pmid: 10488178
references.citation: Med Mycol. 1999 Jun;37(3):169-74
references.pmid: 10421848
references.citation: J Clin Invest. 2005 Mar;115(3):632-41
references.pmid: 15765146
references.citation: AIDS. 2002 May 3;16(7):1031-8
references.pmid: 11953469
references.citation: Curr Opin Microbiol. 2013 Aug;16(4):409-13
references.pmid: 23588027
references.citation: Am J Clin Pathol. 1976 Jan;65(1):83-92
references.pmid: 1246992
references.citation: Eukaryot Cell. 2005 Aug;4(8):1420-33
references.pmid: 16087747
references.citation: Curr Opin Microbiol. 2003 Aug;6(4):332-7
references.pmid: 12941400
references.citation: Med Mycol. 2010 Aug;48(5):775-9
references.pmid: 20233022
references.citation: Pediatrics. 2001 May;107(5):E66
references.pmid: 11331716
references.citation: Infect Immun. 1988 Nov;56(11):2794-800
references.pmid: 3049374
references.citation: J Clin Invest. 2008 Mar;118(3):1186-97
references.pmid: 18259613
references.citation: Infect Immun. 2000 Jun;68(6):3724-6
references.pmid: 10816535
references.citation: Genome Res. 2002 Sep;12(9):1445-53
references.pmid: 12213782
references.citation: Eukaryot Cell. 2003 Dec;2(6):1336-49
references.pmid: 14665467
references.citation: PLoS One. 2013;8(1):e55110
references.pmid: 23383070
references.citation: BMC Genomics. 2008;9:417
references.pmid: 18796135
references.citation: MBio. 2010 May 18;1(1):null
references.pmid: 20689742
references.citation: J Immunol. 2004 Sep 1;173(5):3357-65
references.pmid: 15322199
references.citation: PLoS Pathog. 2010;6(6):e1000945
references.pmid: 20585557
references.citation: Mol Microbiol. 2008 Sep;69(6):1456-75
references.pmid: 18673460
references.citation: BMC Infect Dis. 2007;7:84
references.pmid: 17655757
references.citation: Future Microbiol. 2010 Aug;5(8):1269-88
references.pmid: 20722603